This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Lifecell Corporation. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Martin J. Byrne: Innovating Tissue Bioburden Reduction
Introduction: Martin J. Byrne is a distinguished inventor based in Hellertown, PA, renowned for his contributions to the field of tissue product innovations. With a focus on enhancing the quality and safety of tissue products, Byrne has gained recognition for his inventive approach to reducing bioburden.
Latest Patents: Martin J. Byrne holds a patent for a groundbreaking method titled "Electroporation of Tissue Products." This innovative technique offers effective methods for reducing bioburden on tissue products, presenting significant advancements in the medical field. The patented method involves electroporating tissue while utilizing one or more bactericides, leading to decreased bioburden with reduced exposure to electrical energy and bactericides.
Career Highlights: Currently, Martin J. Byrne is affiliated with Lifecell Corporation, where he continues to drive advancements in tissue technology. His work contributes to the company's mission of improving medical outcomes through innovative tissue solutions. With one patent to his name, Byrne stands out as a valuable member of the inventing community.
Collaborations: Throughout his career, Martin J. Byrne has collaborated with esteemed colleagues such as Gary Monteiro and Rick T. Owens. These partnerships have fostered a dynamic environment of innovation, allowing for the exchange of ideas and expertise, ultimately enhancing the effectiveness and safety of tissue products.
Conclusion: Martin J. Byrne exemplifies the spirit of innovation in the realm of tissue bioburden reduction. His patented methods and ongoing contributions at Lifecell Corporation signify his commitment to improving healthcare outcomes. As the field continues to evolve, Byrne's work serves as a foundation for future advancements in tissue technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
